InvestorsObserver
×
News Home

Is Atara Biotherapeutics Inc (ATRA) a Leader in the Healthcare Sector?

Friday, June 24, 2022 12:24 PM | InvestorsObserver Analysts

Mentioned in this article

Is Atara Biotherapeutics Inc (ATRA) a Leader in the Healthcare Sector?

The 27 rating InvestorsObserver gives to Atara Biotherapeutics Inc (ATRA) stock puts it near the top of the Healthcare sector. In addition to scoring higher than 70 percent of stocks in the Healthcare sector, ATRA’s 27 overall rating means the stock scores better than 27 of all stocks.

Overall Score - 27
ATRA has an Overall Score of 27. Find out what this means to you and get the rest of the rankings on ATRA!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 27 means the stock is more attractive than 27 percent of stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Atara Biotherapeutics Inc Stock Today?

Atara Biotherapeutics Inc (ATRA) stock has fallen -1.9% while the S&P 500 has gained 2.34% as of 12:18 PM on Friday, Jun 24. ATRA is down -$0.14 from the previous closing price of $7.35 on volume of 609,577 shares. Over the past year the S&P 500 is lower by -8.95% while ATRA is down -56.51%. ATRA lost -$3.65 per share the over the last 12 months. Click Here to get the full Stock Report for Atara Biotherapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App